Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001148

Drug Information
Synonymscyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-; CHEBI:138833; Ketamine Base; MolPort-001-838-070; NCGC00159480-02; Ketoject; ketamine; DEA No. 7285; C13H16ClNO; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (.+/-.)-; dl-Ketamine; (+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone; Ketaminum [INN-Latin]; Ketalar base; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI); Special K [street name]; Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (.+-.)-; Calypsol; KBio1_000217; NINDS_000217; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (.+-.)-; C07525; KETAMINE HCL; LS-57301; 2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone; NSC70151; MLS001331674; 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one; AC1L1GSH; AC1Q40UR; Cetamina; 79499-51-7; Ketaminum; Ketaject; 100477-72-3; Tekam; 2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone; Ketolar; CHEBI:6121; Tekam (TN); (+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone; AKOS001053247; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI); CLSTA 20; 33643-45-7; CI-581; D08098; CHEMBL742; CID3821; CI 581 base; Special K; (+-)-Ketamine; 6740-88-1; BRN 2216965; Ketanest; Ketamine [INN:BAN]; Ketamine (INN); Ketalar; SMR000238141; Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+-)-; DB01221; NSC 70151; EINECS 229-804-1; Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI); (+/-)-Ketamine; DivK1c_000217; IDI1_000217; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-; 2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+/-)-; Green; Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-; 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone; UNII-690G0D6V8H; NCGC00159480-03; Cetamina [INN-Spanish]; T385    
Trade NameKetanest; Ketaset; Ketalar    
CompanyPfizer Pharmaceuticals    
IndicationAnestheticApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnalgesics    
CAS NumberCAS 6740-88-1
PubChem Compound IDCID 3821.    
PubChem Substance IDSID 9728.    
SuperDrug ATC IDN01AX03;    
SuperDrug CAS ID006740881;    
TargetN-methyl-D-aspartate (NMDA) receptorAntagonist[2][3][4]
Ref 1Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec;7(17):2385-401. To Reference
Ref 2Ketamine Modulates Theta and Gamma Oscillations. J Cogn Neurosci. 2009 Jul 7. [Epub ahead of print] To Reference
Ref 3Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. To Reference
Ref 4Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381-91. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543